SoftOx Solutions AS (SOFTX) - Total Liabilities
Based on the latest financial reports, SoftOx Solutions AS (SOFTX) has total liabilities worth Nkr17.26 Million NOK (≈ $1.82 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore SoftOx Solutions AS equity growth rate to track the company's year-over-year net asset growth rate.
SoftOx Solutions AS - Total Liabilities Trend (2016–2024)
This chart illustrates how SoftOx Solutions AS's total liabilities have evolved over time, based on quarterly financial data. See how much free cash does SoftOx Solutions AS generate to measure how efficiently the company converts operating cash flow to free cash.
SoftOx Solutions AS Competitors by Total Liabilities
The table below lists competitors of SoftOx Solutions AS ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Altech Chemicals Ltd
F:A3Y
|
Germany | €16.45 Million |
|
YOC AG
F:YOC
|
Germany | €13.25 Million |
|
OD6 Metals Ltd
AU:OD6
|
Australia | AU$1.12 Million |
|
Xu Yuan Packaging Technology Co Ltd
TWO:8421
|
Taiwan | NT$1.15 Billion |
|
Alankit Limited
NSE:ALANKIT
|
India | Rs1.15 Billion |
|
Flagship Investments Ltd
AU:FSI
|
Australia | AU$21.28 Million |
|
Inalways
TWO:5398
|
Taiwan | NT$70.17 Million |
|
Petratherm Ltd
AU:PTR
|
Australia | AU$466.42K |
Liability Composition Analysis (2016–2024)
This chart breaks down SoftOx Solutions AS's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see how much is SoftOx Solutions AS worth.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.16 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.17 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.15 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how SoftOx Solutions AS's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for SoftOx Solutions AS (2016–2024)
The table below shows the annual total liabilities of SoftOx Solutions AS from 2016 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | Nkr25.96 Million ≈ $2.73 Million |
-72.64% |
| 2023-12-31 | Nkr94.87 Million ≈ $9.98 Million |
+53.45% |
| 2022-12-31 | Nkr61.83 Million ≈ $6.51 Million |
+237.34% |
| 2021-12-31 | Nkr18.33 Million ≈ $1.93 Million |
+65.23% |
| 2020-12-31 | Nkr11.09 Million ≈ $1.17 Million |
-40.03% |
| 2019-12-31 | Nkr18.50 Million ≈ $1.95 Million |
+105.86% |
| 2018-12-31 | Nkr8.98 Million ≈ $945.45K |
+114.38% |
| 2017-12-31 | Nkr4.19 Million ≈ $441.01K |
-34.30% |
| 2016-12-31 | Nkr6.38 Million ≈ $671.23K |
-- |
About SoftOx Solutions AS
SoftOx Solutions AS, together with its subsidiaries, operates as a clinical-stage pharmaceutical company that develops antimicrobials products for infection prevention and treatment in Norway. The company develops SoftOx Inhalation Solution, an inhalation solution that is phase II clinical trial for the treatment of ventilator associated pneumonia and other airway infections. It also developing p… Read more